Featured
-
Rally Time: Digital Brands Group Stock Is Soaring A/H…Here’s Why ($DBGI)
Digital Brands Group shares rallied into the close, finishing the day roughly 6% higher with trading volume more than 7X…
Read More » -
Adamas One Corp. Is Cut And Polished For Success, Seizes A More Than $100 Billion Diamond Market Opportunity
Diamonds aren’t just a girl’s best friend – they also present massive revenue-generating opportunities for innovative companies changing the landscape…
Read More » -
With A Pocket Full Of Cash, Digital Brands Group Could Create A Brand Powerhouse ($DBGI)
Digital Brands Group, Inc. (NASDAQ: DBGI, $DBGI) stock has had a rough ride of late. Then again, few stocks, especially…
Read More » -
Acurx Pharmaceuticals Update Validates Front Line CDI Treatment In Play ($ACXP)
Acurx Pharmaceuticals (NASDAQ: ACXP) provided an update showing that its position to bring a front-line treatment against CDI is on…
Read More » -
Goldman SCR Forecasts Massive Surge In First Wave Biopharma Stock ($FWBI)
First Wave BioPharma ($FWBI), a clinical-stage biopharmaceutical company specializing in developing targeted, non-systemic therapies for gastrointestinal (GI) diseases, earned a…
Read More » -
Winc Inc Shares Remain A Tasty Proposition ($WBEV)
Winc, Inc. (NYSE American: WBEV, $WBEV) shares look extremely undervalued after releasing its Q4 and FY2021 earnings earlier this month.…
Read More » -
First Wave BioPharma Forms Clinical Steering Committee Focused on Advancing Inflammatory Bowel Disease (IBD) Product Portfolio ($FWBI)
First Wave BioPharma,Inc., (NASDAQ:FWBI), a clinical-stage biopharmaceutical company specializing in the development of targeted, non-systemic therapies for gastrointestinal (GI) diseases,…
Read More » -
Digital Brands Group Stock Grossly Undervalued; And 600% Upside Is Indeed In Play ($DBGI)
Digital Brands Group, Inc. ($DBGI) stock is massively undervalued. And Rob Goldman, lead analyst at Goldman Small Cap Research, agrees.…
Read More » -
Acurx Pharmaceuticals Emerges As The New CDI Treatment Leader…Here’s Why ($ACXP)
Acurx Pharmaceuticals’ (NASDAQ: ACXP) is stalking its opportunity to become the front-line CDI treatment against C. difficile (CDI). In fact, after Pfizer…
Read More » -
AppTech Payments Corp Stock Jumps More Than 80% As Fintech Gets Red-Hot ($APCX)
AppTech Payments Corp. (NASDAQ: APCX, $APCX) shares have surged by more than 65%* since March. But that doesn’t mean they’re…
Read More »